Net Sales of $172.8 Million, up 161 Percent; Adjusted EBITDA of $76.1 Million, up 254 Percent; Adjusted Operating Cash Flow of $129.6 Million; GAAP Operating Cash Flow of $41.6 Million; Confirms Recently Raised Full-Year 2015 Sales and Adjusted EBITDA Guidance; Conference Call and Webcast at 8:00 a.m. EDT, August 7th
DUBLIN, IRELAND--(Marketwired - Aug 7, 2015) - Horizon Pharma plc (NASDAQ: HZNP), a biopharmaceutical company focused on improving patients’ lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, announced its second-quarter 2015 financial results today.
Help employers find you! Check out all the jobs and post your resume.
